Dear All,
It is soon expected that Trump Administration will issue an "Executive Order" on drug pricing. I feel some heat from pharmaceutical industry.
For this, would you share your views on how firms (new drugs and GENERICS) should prepare for this new policy?
FYI: Trump previously stated "drugmakers are getting away with murder."
Sharing your perceptive views would be appreciated.
In particular, what are the potential action items for pharmaceuticals to consider and implement?
Thank you.
s/ David
______________________________________________
Dr. David Lim, Ph.D., RAC, ASQ-CQA
REGULATORY DOCTOR
Phone (Toll-Free): 1-(800) 321-8567
NOTICE: This communication (including any attachments) may contain privileged or confidential information intended for a specific individual and purpose, and is protected by law. If you are not the intended recipient, you should delete this communication and/or shred the materials and any attachments and are hereby notified that any disclosure, copying or distribution of this communication, or the taking of any action based on it, is strictly prohibited.